148 related articles for article (PubMed ID: 12163111)
1. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
Dupouy V; Zajac JM
Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
[TBL] [Abstract][Full Text] [Related]
3. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
4. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
Courteix C; Coudoré-Civiale MA; Privat AM; Zajac JM; Eschalier A; Fialip J
Br J Pharmacol; 1999 Jul; 127(6):1454-62. PubMed ID: 10455296
[TBL] [Abstract][Full Text] [Related]
5. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
Gouardères C; Sutak M; Zajac JM; Jhamandas K
Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
[TBL] [Abstract][Full Text] [Related]
6. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
[TBL] [Abstract][Full Text] [Related]
7. Dual localization of neuropeptide FF receptors in the rat dorsal horn.
Gouardères C; Roumy M; Advokat C; Jhamandas K; Zajac JM
Synapse; 2000 Jan; 35(1):45-52. PubMed ID: 10579807
[TBL] [Abstract][Full Text] [Related]
8. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF.
Francés B; Lahlou H; Zajac JM
Regul Pept; 2001 Apr; 98(1-2):13-8. PubMed ID: 11179773
[TBL] [Abstract][Full Text] [Related]
9. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
Dupouy V; Zajac JM
Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
[TBL] [Abstract][Full Text] [Related]
11. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
Fang Q; Jiang TN; Li N; Han ZL; Wang R
Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
[TBL] [Abstract][Full Text] [Related]
12. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain.
Desprat C; Zajac JM
Brain Res Dev Brain Res; 1994 Oct; 82(1-2):118-26. PubMed ID: 7842499
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
[TBL] [Abstract][Full Text] [Related]
14. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice.
Marchand S; Betourne A; Marty V; Daumas S; Halley H; Lassalle JM; Zajac JM; Frances B
Peptides; 2006 May; 27(5):964-72. PubMed ID: 16494968
[TBL] [Abstract][Full Text] [Related]
15. Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study.
Quelven I; Roussin A; Zajac JM
Neuroscience; 2004; 126(2):441-9. PubMed ID: 15207362
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide FF, pain and analgesia.
Roumy M; Zajac JM
Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum.
Takeuchi T; Fujita A; Roumy M; Zajac JM; Hata F
Jpn J Pharmacol; 2001 Aug; 86(4):417-22. PubMed ID: 11569615
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
Quelven I; Roussin A; Zajac JM
Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
Kotlinska J; Pachuta A; Dylag T; Silberring J
Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
